Position in EPRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$452,454
-$95,252 QoQ
Shares Held
68,450
-9.5% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 68 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026INGALLS & SNYDER LLC holds $733,965,925 across 13 Biotechnology names. EPRX ranks #7 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
7,934,507 | $689,905,383 | |
| 2 | OMER |
Omeros Corp
|
3,659,523 | $34,802,063 | |
| 3 | HYFT |
MindWalk Holdings Corp.
|
3,035,479 | $4,796,056 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,903 | $1,442,007 | |
| 5 | GMAB |
Genmab A/S
|
50,841 | $1,396,602 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
7,339 | $574,423 | |
| 7 | EPRX |
Eupraxia Pharmaceuticals Inc.
This page
|
68,450 | $452,454 | |
| 8 | VCEL |
Vericel Corp
|
5,000 | $222,450 |
All Filings in EPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $452,454 | 68,450 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $547,706 | 75,650 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $584,370 | 77,400 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $348,690 | 59,100 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $214,272 | 37,200 | Shares | Other | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||